Long-Acting 2-Agonists in Asthma: Safety Concerns

CMAJ - Canada
doi 10.1503/cmaj.051224
Full Text
Abstract

Available in full text

Categories
Medicine
Date
Authors
Publisher

Joule Inc.

Related search

Long Acting Beta-2 Agonists in the Treatment of Asthma and Their Safety

Tuberkuloz ve Toraks
PulmonaryCritical CareRespiratory MedicineSurgeryIntensive Care Medicine
2011English

Review: Regular Inhaled Long Acting 2 Agonists Are Associated With Better Outcomes Than Short Acting 2 Agonists in Adults and Children With Chronic Asthma

Evidence-based nursing
FundamentalsSkills
2003English

The Debate About the Use of Long-Acting Inhaled ß-Agonists in Asthma

Barcelona Respiratory Network
2017English

The Debate About the Use of Long-Acting Inhaled ß-Agonists in Asthma

Barcelona Respiratory Network
2017English

Prs1 Severe Asthma Exacerbations Associated With Long-Acting Beta Agonists Among Children and Adolescents With Asthma

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2011English

Addition of Long-Acting Beta-Agonists to Inhaled Corticosteroids for Chronic Asthma in Children

2009English

Do Long-Acting Β2-Adrenoceptor Agonists Enhance the Anti-Inflammatory Effect of Glucocorticoids in Asthma?

European Respiratory Journal
MedicinePulmonaryRespiratory Medicine
2001English

Potential Masking Effect on Dyspnoea Perception by Short- And Long-Acting Β2-Agonists in Asthma

European Respiratory Journal
MedicinePulmonaryRespiratory Medicine
2002English

Combination Long-Acting Β-Agonists and Inhaled Corticosteroids Compared With Long-Acting Β-Agonists Alone in Older Adults With Chronic Obstructive Pulmonary Disease

JAMA - Journal of the American Medical Association
Medicine
2014English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy